Results 201 to 210 of about 15,050 (215)

Brolucizumab: Verlängerte Therapieintervalle bei nAMD in Aussicht

Kompass Ophthalmologie, 2021
openaire   +1 more source

nAMD: Warum Patienten von der Behandlung abspringen

Augenheilkunde up2date, 2019
openaire   +2 more sources

NAMD: Biomolecular Simulation on Thousands of Processors

ACM/IEEE SC 2002 Conference (SC'02), 2002
J.C. Phillips, null Gengbin Zheng, S. Kumar, L.V. Kale   +3 more
openaire   +1 more source

OCTA-Based Biomarker Characterization in nAMD

2025 IEEE 6th International Conference on Image Processing, Applications and Systems (IPAS)
Maria Simona Tivadar, Ioana Damian, Adrian Petru Groza, Simona Delia Nicoara   +3 more
openaire   +1 more source

Multiple-Replica Strategies for Free-Energy Calculations in NAMD: Multiple-Walker Adaptive Biasing Force and Walker Selection Rules

Journal of Chemical Theory and Computation, 2014
Jeffrey Comer, James C Phillips, Klaus Schulten   +2 more
exaly  

A generic implementation of replica exchange with solute tempering (REST2) algorithm in NAMD for complex biophysical simulations

Computer Physics Communications, 2015
Sunhwan Jo, Wei Jiang
exaly  

Stereotactic radiotherapy for nAMD: areas for improvement

The Lancet
Dongli Zhao, Beina Hui, Chenchen He, Yiping Qu, Yongkai Lu   +4 more
openaire   +2 more sources

OPTIMIZING TREATMENT OF nAMD.

Retina (Philadelphia, Pa.), 2020
openaire   +1 more source

NAMD goes quantum: an integrative suite for hybrid simulations

Nature Methods, 2018
Marcelo C R Melo, Rafael C Bernardi, Till Rudack   +2 more
exaly  

A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom

Advances in Therapy, 2017
Adrian Skelly, Paul Mitchell
exaly